CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2026-06-27 was $115.60M, a 1472.31% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2026-03-28 was $208.28M, a 41.02% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2025-12-27 was $96.00K, a 22.58% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for the quarter ending 2025-09-27 was $93.00K, a 99.91% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2025 was $360.67M, a 202.64% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2024 was $119.17M, a 393.38% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2023 was $24.16M, a 37.50% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments for repurchase of common stock for fiscal 2022 was $38.65M, a 5.05% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-27 | $115.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $324.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $208.28M 10-Q · filed 2026-05-07 | $215.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-27 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $360.67M 10-K · filed 2026-02-18 |
| 2025-09-27 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $360.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $7.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $461.39M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $353.13M 10-Q · filed 2026-05-07 | $462.96M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-28 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $119.17M 10-K · filed 2026-02-18 |
| 2024-09-28 | $100.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $119.19M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-29 | $8.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $18.44M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-30 | $9.35M 10-Q · filed 2025-05-07 | $14.49M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-30 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $24.16M 10-K · filed 2026-02-18 |
| 2023-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $24.18M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-07-01 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $24.16M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-04-01 | $19.01M 10-Q · filed 2024-05-09 | $23.67M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $38.65M 10-K · filed 2025-02-19 |
| 2022-09-24 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $38.76M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-25 | $4.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $38.88M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-26 | $33.99M 10-Q · filed 2023-05-11 | $38.67M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-25 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $40.71M 10-K · filed 2024-02-14 |
| 2021-09-25 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $40.51M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | $4.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $40.48M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | $36.03M 10-Q · filed 2022-05-04 | $36.33M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $23.98M 10-K · filed 2023-02-22 |
| 2020-09-26 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $23.95M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $24.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | $23.68M 10-Q · filed 2021-05-04 | $24.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $18.09M 10-K · filed 2022-02-16 |
| 2019-09-28 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $18.09M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $18.06M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $17.76M 10-Q · filed 2020-05-07 | $18.06M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $13.85M 10-K · filed 2021-02-17 |
| 2018-09-29 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $13.80M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $49.76M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-03-31 | $13.55M 10-Q · filed 2019-05-07 | $72.28M derived: sum of 4 quarters · filed 2020-02-11 |
| 2017-12-30 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $106.91M 10-K · filed 2020-02-11 |
| 2017-09-30 | $36.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $106.94M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-07-01 | $22.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $70.89M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-04-01 | $48.18M 10-Q · filed 2018-05-10 | $48.30M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $12.27M 10-K · filed 2019-02-13 |
| 2016-09-24 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $12.27M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-25 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $30.19M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-26 | $12.15M 10-Q · filed 2017-05-10 | $70.99M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-26 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $117.48M 10-K · filed 2018-02-13 |
| 2015-09-26 | $17.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $117.46M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | $40.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $119.89M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | $58.63M 10-Q · filed 2016-05-04 | $159.84M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $122.02M 10-K · filed 2017-02-14 |
| 2014-09-27 | $20.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $196.21M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $80.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $240.64M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $20.81M 10-Q · filed 2015-04-30 | $175.51M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $74.23M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $165.93M 10-K · filed 2016-02-12 |
| 2013-09-28 | $64.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $110.05M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $15.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $60.27M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | $11.23M 10-Q · filed 2014-04-30 | $60.17M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | $18.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $64.19M 10-K · filed 2015-02-17 |
| 2012-09-29 | $15.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $74.03M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $15.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $123.50M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $15.25M 10-Q · filed 2013-05-08 | $124.58M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $28.18M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $283.80M 10-K · filed 2014-02-25 |
| 2011-09-24 | $64.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $255.72M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $16.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $544.67M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $174.47M 10-Q · filed 2012-05-04 | $528.10M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-25 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $356.53M 10-K · filed 2013-02-27 |
| 2010-09-25 | $353.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $356.55M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-26 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $3.70M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-27 | $2.90M 10-Q · filed 2011-05-04 | |
| 2009-12-26 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $45.90M 10-K · filed 2012-02-27 |
| 2009-09-26 | $606.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | |
| 2008-12-27 | $115.06M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |